SCHEMBL8312751

SCHEMBL8312751

CC(C)C(=O)N[C@@H]1C[N@@]2CC[C@@H]1C2

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 2/20 0.45
CHRM2 P08172 1/20 0.45
CHRM3 P20309 1/20 0.45
CA12 O43570 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA9 Q16790 3/20 0.41
CHRNA7 P36544 3/20 0.41
HTR3A P46098 2/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
HTR3E A5X5Y0 1/20 0.40
HTR3B O95264 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
HTR3D Q70Z44 1/20 0.40
HTR3C Q8WXA8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8324789 1.00 CHRM1 (0.45) CHRM1CHRM2CHRM3CA12CA1
SCHEMBL18347995 0.91 CHRM2 (0.52) CHRM1CHRM2CHRM3CA12CA1
SCHEMBL12920577 0.91 CHRM2 (0.52) CHRM1CHRM2CHRM3CA12CA1
SCHEMBL18347958 0.91 CHRM2 (0.52) CHRM1CHRM2CHRM3CA12CA1
SCHEMBL14577530 0.76 CHRM3 (0.48) CHRM1CHRM2CHRM3CA12CA1
SCHEMBL14611981 0.76 CHRM1 (0.45) CHRM1CA12CA1CA2CA9
SCHEMBL14611982 0.76 CHRM1 (0.45) CHRM1CA12CA1CA2CA9
SCHEMBL10280321 0.76 CHRM3 (0.48) CHRM1CHRM2CHRM3CA12CA1
SCHEMBL14611984 0.76 CHRM1 (0.45) CHRM1CA12CA1CA2CA9
SCHEMBL14577614 0.76 CHRM3 (0.48) CHRM1CHRM2CHRM3CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004052348-A2 TREATMENT OF DISEASES WITH COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS AND OTHER COMPOUNDS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-06-24 WO disclosed
WO-2004039366-A1 NICOTINIC ACETYLCHOLINE AGONISTS IN THE TREATMENT OF GLAUCOMA AND RETINAL NEUROPATHY PHARMACIA & UPJOHN COMPANY LLC (US) 2004-05-13 WO disclosed